92 related articles for article (PubMed ID: 2059759)
21. Microbial contamination of BM products before and after processing: a report of incidence and immediate adverse events in 257 grafts.
Vanneaux V; Foïs E; Robin M; Rea D; de Latour RP; Biscay N; Chantre E; Robert I; Wargnier A; Traineau R; Benbunan M; Marolleau J; Socié G; Larghero J
Cytotherapy; 2007; 9(5):508-13. PubMed ID: 17786612
[TBL] [Abstract][Full Text] [Related]
22. [ABO-incompatible allogeneic bone marrow transplantation].
Xu L; Guo N; Wang S
Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):413-5. PubMed ID: 11721421
[TBL] [Abstract][Full Text] [Related]
23. Incidence of bacterial contamination of bone marrow grafts.
Schepers KG; Davis JM; Rowley SD
Prog Clin Biol Res; 1992; 377():379-84. PubMed ID: 1438434
[No Abstract] [Full Text] [Related]
24. Adverse reactions in patients transfused with cryopreserved marrow.
Stroncek DF; Fautsch SK; Lasky LC; Hurd DD; Ramsay NK; McCullough J
Transfusion; 1991; 31(6):521-6. PubMed ID: 1853447
[TBL] [Abstract][Full Text] [Related]
25. [Prophylaxis of Gram-positive infections after bone marrow graft. Controlled study of the 6-day administration of vancomycin. Intermediate analysis of 60 patients].
Maraninchi D; Hartman O; Benhamou E; Viens P; Blaise D; Vassal G; Gaspard MH; Kalifa C; Stoppa AM; Patte C
Pathol Biol (Paris); 1988 Sep; 36(7):915-9. PubMed ID: 3059277
[TBL] [Abstract][Full Text] [Related]
26. [Technical aspects of autologous bone marrow transplantation].
Handgretinger R; Klingebiel T; Niethammer D
Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():39-41. PubMed ID: 7841779
[TBL] [Abstract][Full Text] [Related]
27. Autologous bone marrow transplantation for leukemia.
Stuart RK
Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
[TBL] [Abstract][Full Text] [Related]
28. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells.
Hoyt R; Szer J; Grigg A
Bone Marrow Transplant; 2000 Jun; 25(12):1285-7. PubMed ID: 10871734
[TBL] [Abstract][Full Text] [Related]
29. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
[TBL] [Abstract][Full Text] [Related]
30. Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide.
Kalaycioglu M; Copelan E; Avalos B; Klein J; Goormastic M; Bolwell B
Bone Marrow Transplant; 1995 Jan; 15(1):105-10. PubMed ID: 7742742
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
[TBL] [Abstract][Full Text] [Related]
32. Reported contamination of heparin sodium with Pseudomonas putida.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Feb; 35(8):123-4. PubMed ID: 3080667
[No Abstract] [Full Text] [Related]
33. Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae.
Klein MA; Kadidlo D; McCullough J; McKenna DH; Burns LJ
Biol Blood Marrow Transplant; 2006 Nov; 12(11):1142-9. PubMed ID: 17085307
[TBL] [Abstract][Full Text] [Related]
34. Clinical and laboratory experience in marrow harvesting in children for autologous bone marrow transplantation.
Cairo MS; VandeVen C; Toy C; Sender L
Bone Marrow Transplant; 1989 May; 4(3):305-8. PubMed ID: 2659115
[TBL] [Abstract][Full Text] [Related]
35. Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipients.
De Pauw BE; Donnelly JP; De Witte T; Nováková IR; Schattenberg A
Bone Marrow Transplant; 1990 Mar; 5(3):179-82. PubMed ID: 2184908
[TBL] [Abstract][Full Text] [Related]
36. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
Romano V; Castagnola E; Dallorso S; Lanino E; Calvi A; Silvestro S; Morreale G; Giacchino R; Dini G
Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259
[TBL] [Abstract][Full Text] [Related]
37. Microbial contamination of peripheral blood stem cell collections.
Attarian H; Bensinger WI; Buckner CD; McDonald DL; Rowley SD
Bone Marrow Transplant; 1996 May; 17(5):699-702. PubMed ID: 8733684
[TBL] [Abstract][Full Text] [Related]
38. Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course.
Avery R; Kalaycio M; Pohlman B; Sobecks R; Kuczkowski E; Andresen S; Mossad S; Shamp J; Curtis J; Kosar J; Sands K; Serafin M; Bolwell B
Bone Marrow Transplant; 2005 Mar; 35(5):497-9. PubMed ID: 15640812
[TBL] [Abstract][Full Text] [Related]
39. Use of cryopreserved bone marrow in unrelated allogeneic transplantation.
Stockschläder M; Krüger W; tom Dieck A; Horstmann M; Altnöder M; Löliger C; Fiedler W; Hoffknecht M; Erttmann R; Zander A
Bone Marrow Transplant; 1996 Feb; 17(2):197-9. PubMed ID: 8640166
[TBL] [Abstract][Full Text] [Related]
40. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
